Ana sayfa
Piyasalar
Grafikler ve fikirler
Algo
Haberler
Store
Aracı kurumlar
İndir
Ekonomik Takvim
Alım-satım sinyalleri
Web Terminali
Arama yapmak için
/
tuşuna basın: @kullanıcı, $sembol, ...
Ara
Giriş yap
Hesap oluştur
Türkçe
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
MLTX
#2020
MoonLake Immunotherapeutics Class A Ordinary Shares
17.510
0
-0.68%
Sektör:
Baz:
Kar para birimi:
Günlük aralık
Yıllık aralık
Günlük değişim
-0.68%
Aylık değişim
+7.49%
6 aylık değişim
+83.16%
Yıllık değişim
+83.16%
Önceki kapanış
17.630
0
Open
17.510
0
Bid
Ask
Low
17.510
0
High
17.510
0
Hacim
76
Piyasalar
ABD hisse senetleri
Sağlık hizmetleri
MLTX
Open full chart
Financials
Overview
Rapor
Statistics
Dividends
Quarterly
Annual
Value
2020
2021
2022
2023
2024
2025
TTM
Key stats
Total common shares outstanding
11.93 M
11.93 M
39.15 M
62.87 M
63.28 M
71.73 M
—
Valuation ratios
Enterprise value
—
—
1.72 B
10.98 B
10.22 B
2.5 B
19.59 B
Price to earnings ratio
—
—
-6.49
-81.58
-28.65
-3.73
-39.86
Price to sales ratio
—
—
995.06
19.31 K
-80.7 K
1 418.42
3 765.23
Price to cash flow ratio
—
—
-5.79
-68.38
-29.2
4.33
-27.34
Price to book ratio
—
—
6.62
5.9
7.62
2.79
6.17
Enterprise value to EBITDA ratio
—
—
—
—
—
—
—
Profitability ratios
Return on assets %
—
-0.04
-0.65
-0.07
-0.25
0.54
0.51
Return on equity %
—
0.64
-0.73
-0.07
-0.26
0.75
0.7
Return on invested capital %
—
—
-427.73
-1 699.61
-2 635.87
2 828.78
2 975.79
Gross margin %
—
—
100
100
100
100
400
Operating margin %
—
—
-20 K
-35.73 K
339.19 K
40.87 K
97.97 K
EBITDA margin %
—
—
—
—
—
—
—
Net margin %
—
—
-15.36 K
-23.77 K
281.93 K
37.95 K
77.78 K
Liquidity ratios
Quick ratio
—
—
—
—
—
—
—
Current ratio
12.93
0.21
9.98
51.59
21.11
9.27
55.53
Inventory turnover
—
—
—
—
—
—
—
Asset turnover
—
—
0
0
-0
0
0
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
—
Long term debt to total assets ratio
0
0
—
—
—
0.17
0.65
Long term debt to total equity ratio
0.01
0
—
—
—
0.24
0.89
Per share metrics
Operating cash flow per share
—
-0
-1.9
-0.87
-1.85
3.04
3.08
EBIT per share
—
—
—
—
—
—
—
EBITDA per share
—
—
—
—
—
—
—
Total debt per share
—
—
—
—
—
—
—
Cash per share
—
0
2.46
10.4
7.13
6.11
26.43
Net current asset value per share
—
0
2.61
10.47
7.54
6.54
28.23
Tangible book value per share
—
-0.02
1.67
10.09
7.11
4.72
21.32
Working capital per share
—
-0.01
2.34
10.26
7.19
5.84
25.95
Book value per share
—
-0.02
1.67
10.09
7.11
4.72
21.32
Haberler
MoonLake: Downgrade To Buy As Sonelokimab Still Has A BLA Shot On Goal (NASDAQ:MLTX)
MoonLake Immunotherapeutics (MLTX) Analyst/Investor Day - Slideshow (NASDAQ:MLTX) 2026-02-23
MoonLake Immunotherapeutics (MLTX) Analyst/Investor Day Transcript
MoonLake hisseleri pozitif axSpA deneme verileriyle yükseldi
MoonLake stock surges on positive axSpA trial data
MoonLake hissesi InvestingPro Gerçeğe Uygun Değer çağrısı sonrası %63 yükseldi
MoonLake stock surges 63% after InvestingPro Fair Value call
MoonLake aksiyel spondiloartrit için olumlu faz 2 verisi açıkladı
MoonLake reports positive phase 2 axial spondyloarthritis data
ImageneBio, Dr. Porter-Brown’ı Tıbbi Direktör olarak atadı
ImageneBio appoints Dr. Porter-Brown as Chief Medical Officer
BTIG, Moonlake Immunotherapeutics hissesi için veri öncesi Al notunu yineliyor